US New Issuance Market Update

• The U.S. Equity New Issuance Market priced 166 deals (41 IPOs, 110 FOs, 15 CVTs) for $40.7B in aggregate proceeds, just below the 167 deals seen the prior year.
• Despite the similar deal count during the same time period last year, the amount of proceeds raised rose 59% year-over-year from $25.6B to $40.7B, largely due to seven issuers raising more than $1.0B in proceeds.
• Overall, 41 IPOs hit the market for $9.1B in combined proceeds, up marginally from the 37 IPOs that raised $3.1B in proceeds the analogous quarter the prior year.
• Continuing the trend seen Q1 and Q2, volumes were driven by Follow-On offerings as 110 deals priced, down 5% from the 116 deals seen in Q2 2022
• The largest deal of the quarter came from Arm Holdings Limited as the tech company raised $5.2B from its IPO offering in September. The issue priced at $51 per share, which was the high end of its initial filing range and saw a 25% uptick in its first day of trading. It was the largest tech IPO since Uber Technologies, Inc. raised $8.1B in May 2019.
• The second largest deal of the quarter came in the form of a follow-on, with AerCap Holdings N.V. raised $2.4B in proceeds out of the financials sector.
• The healthcare sector remained the most active with 50 deals coming to market for $8.9B in proceeds, highlighted by AmerisourceBergen Corp.'s $2.0B Follow-On offering in August

US IPO Pipeline

• Currently there are 62 IPOs in the six-month backlog, with the healthcare and industrials sectors appearing to be the most active with 12 issuers each in the pipeline.
• The largest expected deal is Lexeo Therapeutics, hailing out of the healthcare sector, seeking to raise $126.0M in total proceeds.
• Despite the lack of IPO activity, several unicorn IPOs such as Stripe, Databricks, and Chime remain hopeful to hit the market in 2024.

S&P Global provides industry-leading data, software and technology platforms and managed services to tackle some of the most difficult challenges in financial markets. We help our customers better understand complicated markets, reduce risk, operate more efficiently and comply with financial regulation.

This article was published by S&P Global Market Intelligence and not by S&P Global Ratings, which is a separately managed division of S&P Global.